Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Radiation in Pediatric Medulloblastoma
NCT02681705Phase 2Unknown
- Sponsor
- Xinhua Hospital
- Start
- Jan 2010
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temozolomide in medulloblastoma, sponsored by Xinhua Hospital. Primary endpoint: Number of participants with treatment-related adverse events. Status: unknown.
02
Drugs
temozolomide
03
Conditions
medulloblastoma
Beyond the preview
Go deeper on NCT02681705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02681705.